What Is LOQ? The Limit of Quantitation Explained

The limit of quantitation, commonly abbreviated LOQ (sometimes written LoQ), is the lowest concentration of a substance that a measurement method can reliably put a number on. Below the LOQ, your instrument might still detect that something is there, but it cannot tell you how much with acceptable accuracy and precision. The distinction matters more than it might seem: in clinical medicine, food safety, environmental monitoring, and pharmaceutical development, the LOQ is often the line between actionable data and educated guessing.

LOQ, LOD, and LOB Are Not the Same Thing

Three related terms describe what happens at the low end of a measurement system’s range, and they are frequently confused. The limit of blank (LOB) is the highest signal you would expect to see when measuring a sample that contains none of the substance in question. Every instrument produces some background noise, and the LOB puts a ceiling on that noise. The limit of detection (LOD) is the lowest concentration that can be reliably distinguished from that blank noise. And the LOQ sits above both: it is the lowest concentration where the measurement meets predefined goals for both bias and imprecision.¹

Think of it this way. You are in a dark room trying to spot a candle flame at increasing distances. At some point, you can just barely tell there is a light (that is the LOD). But you cannot say whether it is one candle or three until you move closer, to a distance where your eyes can resolve the flame clearly enough to count (that is the LOQ). The gap between “I see something” and “I can measure how much” is exactly the gap between detection and quantitation.

The LOQ can sit right at the LOD in some well-optimized systems, but in many real-world methods it lands at a much higher concentration.¹ How far apart they are depends on the instrument, the sample type, and how strict your accuracy requirements are.

How LOQ Is Calculated

There is no single universal formula. Different regulatory frameworks and scientific disciplines use different approaches, but two methods dominate: the signal-to-noise approach and the calibration-curve approach.

The signal-to-noise method is intuitive. Every analytical instrument produces background noise alongside the actual signal from the substance you are measuring. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals (ICH) suggests that for LOD, a signal-to-noise ratio of about 3:1 is sufficient, while for LOQ the ratio should be roughly 10:1.² In plain terms, the analyte’s signal needs to be about ten times louder than the background hum before you can trust the number your instrument gives you.

The calibration-curve method works differently. You prepare a series of known concentrations of your target substance, measure the instrument’s response, and draw a line through the data points. LOQ is then calculated using the formula LOQ = 10σ / S, where σ represents the variability of the response and S is the slope of the calibration curve. An example from ICH guidance: with a standard deviation of about 0.43 and a slope of about 1.93, the LOQ works out to roughly 2.2 ng/mL for that particular method.³ The same formula applied with a multiplier of 3.3 instead of 10 gives the LOD, which in that example was about 0.74 ng/mL. The threefold difference between those multipliers is why the LOQ is typically about three times higher than the LOD.

Neither method is inherently better. The signal-to-noise approach is practical and fast but can be subjective, since “noise” looks different depending on where you measure it. The calibration-curve approach is more mathematically grounded but depends on how carefully the calibration standards are prepared. Most labs validate their LOQ experimentally by running replicate measurements at the calculated concentration and checking that accuracy and precision actually hit the targets.

Why the Matrix Changes Everything

A method’s LOQ is not a fixed, universal property of the instrument. It changes based on what surrounds the substance you are trying to measure. In analytical chemistry, the surrounding material is called the matrix: blood plasma, river water, ground beef, urine, soil. Each matrix brings its own cocktail of interfering substances that can suppress or amplify the signal from your target compound.

This is why an LOQ determined in pure solvent can be misleadingly optimistic. When scientists validate a method for measuring a protein like interleukin-13 in human blood, for instance, they have to carefully characterize how the blood plasma itself interferes with the assay, often finding that the real-world lower limit of quantification differs from what the clean-solvent experiments suggested.⁴ Fat in a food sample, salt in seawater, proteins in blood, humic acids in soil: all of these can raise the LOQ by adding noise or suppressing signal.

This is also why you will sometimes see different LOQ values reported for the same instrument and the same substance. A mass spectrometer measuring a pesticide residue in lettuce might report a different LOQ than the same instrument measuring the same pesticide in orange juice, because the two food matrices create different levels of interference. If you are comparing LOQ figures between methods or labs, you have to compare matrix to matrix, not just number to number.

LOQ in Clinical Medicine

One of the places LOQ matters most visibly is in managing HIV. Doctors rely on viral load tests to track how much virus is circulating in a patient’s blood, and those numbers directly guide treatment decisions. A viral load that drops below the assay’s LOQ is typically reported as “undetectable,” which for most patients means their antiretroviral therapy is working. The precision of the assay at its lower end is critical: a more precise test can distinguish genuine changes in viral load from the random noise of the measurement process itself, giving clinicians a clearer picture of whether the treatment is actually controlling the virus.⁵

The problem is that different commercially available viral load assays have different LOQs, and they do not always agree near the boundary. A study comparing three major commercial HIV viral load platforms found that while overall correlation between the assays was good, near the lower limit of quantification the agreement was poor, with a statistical measure of agreement (Cohen’s kappa) ranging from just 0.14 to 0.38.⁶ In practical terms, one assay might report a patient’s viral load as “detectable at low levels” while another platform would call the same sample “undetectable.” For patients and doctors, that discrepancy can trigger unnecessary anxiety, extra blood draws, or premature changes in medication.

This scenario is not unique to HIV. Any clinical test that uses a quantitative threshold to guide decisions, from tumor markers in oncology to drug levels in therapeutic monitoring, faces the same challenge at its LOQ. The closer a patient’s result sits to that boundary, the less confident anyone should be in the exact number.

What Happens to Results Below the LOQ

When a measurement comes back below the LOQ, laboratories do not report a precise number. Instead, the result is typically flagged with a qualifier like “< LOQ" or "BQL" (below the quantitation limit). The substance was probably detected, but the concentration cannot be stated with the level of certainty the method requires. This creates a data-handling headache that scientists call left-censored data: you know the value is somewhere between zero and the LOQ, but you do not know where.

This is a bigger deal than it sounds. In food safety surveillance, environmental monitoring, and epidemiological research, large datasets often contain a high proportion of below-LOQ results. How you handle those values can substantially change your conclusions. Substitution methods are common: replacing each below-LOQ result with zero, with the LOQ value itself, or with half the LOQ. International organizations have recommended these substitution approaches, though researchers have increasingly criticized them as statistically flawed for datasets with a large fraction of non-detects.⁷

Why does this matter to a non-scientist? Consider a pesticide residue survey of a thousand food samples. If 40% of results come back below the LOQ and you replace all of them with zero, your average exposure estimate drops. Replace them all with the LOQ value, and the average climbs. A risk assessor working from that same dataset could reach very different conclusions depending on which substitution rule was applied. The choice of how to treat below-LOQ data is not just a statistical technicality; it feeds directly into public health decisions about whether a chemical in your food supply is safe.

Environmental microbial monitoring runs into the same issue. Field data for airborne pathogens or waterborne bacteria often contain large numbers of non-detects, and the right statistical method for handling those gaps depends on how the data are distributed and how the samples were collected.⁸ There is no one-size-fits-all answer, which is part of what makes LOQ-related data analysis genuinely difficult.

Regulatory Frameworks and Validation

Because so much rides on LOQ values, regulatory bodies set detailed requirements for how they must be determined and validated. The ICH Q2 guidelines are the gold standard for pharmaceutical analytical methods, and their 2023 revision (R2) introduced a stronger emphasis on statistical rigor: validation of performance characteristics like accuracy and precision now requires confidence intervals that are compatible with predefined acceptance criteria, not just point estimates that pass a threshold.⁹ The revision also allows sponsors to draw on prior knowledge from development work to support their validation conclusions, which gives experienced labs more flexibility while maintaining rigor.

For bioanalytical methods used in pharmacokinetic and drug safety studies, the validation process is even more involved. Regulators expect laboratories to demonstrate that their method meets criteria for selectivity, specificity, accuracy, precision, recovery, and stability at and near the lower limit of quantification (LLOQ).¹⁰ The LLOQ, which is the specific lowest point on the calibration curve where quantitation is validated, is the number that appears on regulatory submissions and clinical study reports. If a drug developer claims their assay can measure a metabolite down to 1 ng/mL, the regulators want to see replicate data proving that at 1 ng/mL the bias and imprecision are within acceptable bounds.

Different regulatory contexts set different acceptance criteria. The FDA’s bioanalytical guidance, for example, requires that accuracy at the LLOQ be within 20% of the nominal value and that precision (expressed as coefficient of variation) also stay within 20%. For concentrations above the LLOQ, those limits tighten to 15%. The wider tolerance at the LLOQ reflects the inherent difficulty of measuring precisely at the ragged edge of a method’s capability.

Why LOQ Keeps Getting Lower

Across nearly every analytical discipline, LOQ values have been falling steadily for decades. The trend is driven by advances in instrumentation, sample preparation, and data processing. Modern mass spectrometers are vastly more sensitive than their predecessors from even 20 years ago. Better sample cleanup techniques remove more matrix interference, which reduces noise and pulls the LOQ down. And sophisticated software can extract signals from noisy data that would have been invisible to earlier algorithms.

The history of low-level measurement goes back more than a century. Early 20th-century analytical chemistry was focused almost entirely on qualitative questions: is the substance there or not? Quantitative analysis of trace compounds was, as one historical review put it, “the future task.” The concept of a detection limit began to take shape in the 1920s, when the chemist Fritz Feigl coined the German term Erfassungsgrenze (detection limit), but methods for actually estimating that limit were not specified.¹¹ It took decades more for the statistical frameworks we use today to coalesce, and they are still being refined.

On the cutting edge, single-cell and single-molecule techniques are pushing quantitation into territory that would have seemed fantastical a generation ago. Droplet microfluidics, for example, encapsulates individual cells or molecules inside tiny liquid droplets and analyzes them one at a time. One application in food safety used this approach to detect the foodborne pathogen Salmonella at concentrations as low as 50 colony-forming units per milliliter, outperforming conventional plating methods.¹² Another recent advance used agarose-based droplet microfluidics to analyze individual mitochondrial DNA molecules within more than 10,000 individual cells at a throughput of over 700,000 droplets per minute, achieving roughly 95% retention of the target DNA from each cell.¹³

These technologies are not just academic curiosities. As LOQs drop, the practical consequences ripple outward. Environmental regulators can set tighter limits on contaminants because labs can now measure them at lower levels. Pharmaceutical companies can track drug metabolites deeper into the elimination phase. And clinicians can monitor disease markers with greater sensitivity, catching relapses or treatment failures earlier. Each step down in LOQ redraws the line between “we can measure it” and “we can only guess.”

Common Misconceptions About LOQ

A few misunderstandings about LOQ are widespread enough to be worth addressing directly.

The most common is treating “below the LOQ” as “not present.” A result below the LOQ means the substance could not be measured reliably, not that it was absent. If you see a report that says a contaminant was “not detected” or “below the limit of quantitation,” it is tempting to read that as zero. But the substance could be there at a concentration just below what the method can pin down. In regulatory and safety contexts, the distinction between “none” and “some, but we can’t say how much” is critical.

Another misconception is that the LOQ is a fixed property of an instrument. As discussed earlier, the matrix, the sample preparation technique, and even the specific batch of reagents can shift the LOQ. Two labs running the same instrument model and the same analytical protocol can arrive at slightly different LOQs because of differences in their laboratory environments or the quality of their calibration standards. This is one reason regulatory guidelines require labs to validate their own LOQ experimentally rather than just relying on the instrument manufacturer’s specification sheet.

A third is conflating LOQ with LOD. In casual conversation, even among scientists, “limit of detection” and “limit of quantitation” are sometimes used interchangeably. They are not the same thing and the difference is not trivial. A method might detect a substance down to 0.5 ng/mL but only be able to quantitate it reliably above 1.5 ng/mL. If you are making a decision based on how much is there, rather than just whether it is there, the LOQ is the number that matters.

When LOQ Affects You Personally

You encounter LOQ-dependent results more often than you probably realize, even if the term never appears on the reports you see. Drug testing in the workplace uses cutoff concentrations that are set at or near the LOQ of the analytical method. If you have ever had blood work done to check thyroid hormone levels, vitamin D, or testosterone, the laboratory’s LOQ determined whether your result came back as a number or as “too low to measure.” Water quality reports from your municipal supplier list contaminant levels that were measured against method-specific LOQs, and any contaminant below that threshold simply does not appear in the tally.

In food labeling, regulations in many countries allow manufacturers to list certain nutrients or contaminants as “0” or “not detected” when analytical testing returns a result below the LOQ. This means a food label reading “0 g trans fat” does not necessarily mean zero trans fat; it means the amount was below what the test could reliably quantify, which in practice could be a small but nonzero amount. For most people, these trace quantities are irrelevant. But for individuals with severe allergies or for environmental health researchers aggregating data across thousands of samples, the gap between “zero” and “below LOQ” is real and consequential.

If you ever find yourself comparing test results from different laboratories or different time points, ask whether the LOQ of the method changed between measurements. A viral load that was “undetectable” on one platform might register as a low positive on a newer, more sensitive assay, not because the virus got worse, but because the measurement got better. Understanding that the LOQ is a property of the test, not a property of your body, can save you from unnecessary worry when numbers appear to shift at the low end of the scale.